Institute for Immunity, Transplantation and Infection | Institute for Immunity, Transplantation and Infection | Stanford Medicine
Institute for Immunity, Transplantation and Infection
Single vaccine could protect against all coughs, colds and flus, researchers say
Read the BBC News article
Stanford Vaccine Symposium: October 23, 2025
Livestream Recording
Immunology PhD Program
Learn more about the Immunology PhD Program
Vaccine symposium airs multiple ideas for accelerating preventive immunology
Read the article on Stanford Medicine News Center
Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease
Read the Immunity article here
ITI Research
Learn more about ITI's research labs here
Building a better flu vaccine
Read the article on NIH
System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans
Read the Nature Immunology article here
Harnessing the body's natural defenses
If the body were a country, the immune system would be its national guard. And it couldn't ask for a better homeland defense. The immune system is remarkably effective at protecting us against the millions of pathogens that threaten us daily. We have only to see what happens when our immune system is compromised – from disease, for instance, or by immunosuppressant drugs following organ transplantation – to understand the power it wields when it's operating at full strength.
Our goal is to understand and ultimately control how the immune system defends the body at the molecular and cellular levels. ITI teams, comprised of immunologists, pathologists, microbiologists, infectious disease experts, surgeons, scientists, and clinicians, are attacking these challenges from dozens of different avenues and pooling their talents towards achieving this shared goal.
Stanford Human Systems Immunology Center
Center for Human Systems Immunology receives $18.6 million for global immunology challenges, January 15, 2025
The
Stanford Center for Human Systems Immunology
has received a total of $18.6 million in grants from the Bill & Melinda Gates Foundation to tackle some of the world’s biggest infectious disease challenges.
A five-year $15.8 million grant is a renewal of previous funding, starting in 2014, which allowed the center to develop new approaches to diagnosis and vaccination for infectious diseases including tuberculosis, the No. 1 infectious disease killer in the world. The initiative also supported over 50 pilot projects and 45 projects with the
Global Health Discovery Collaboratory
— a network of foundation-funded organizations driving technical innovations in global health.
Read the full article here.
Clockwise from top left: Catherine Blish, Christopher Barnes, Mark Davis, Prasanna Jagannathan, Purvesh Khatri, Nima Aghaeepour
Learn more about CHSI here
Human Immune Monitoring Center
HIMC provides standardized, state-of-the-art immune monitoring assays at the RNA, protein, and cellular level, as well as archiving, reporting, and data mining support for clinical and translational studies. In partnership with the research community, we also work to test and develop new technologies for immune monitoring.
Learn more here
ITI Research
Read some of ITI Faculty's recently published research articles:
Science, February 2026
"Mucosal vaccination in mice provides protection from diverse respiratory threats"
Science Translational Medicine, September 2025
"Afucosylation of anti-dengue IgG is associated with enhanced susceptibility to dengue virus infection postvaccination"
Immunity, August 2025
"A conserved immune dysregulation signature is associated with infection severity, risk factors prior to infection, and treatment response"
PNAS, March 2025
"Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls"
Immunohorizons, February 2025
"Characterization of immune phenotypes in peripheral blood of adult renal transplant recipients using mass cytometry (CyTOF)"
Read more about research at ITI here
April 24
Apr 24
2026
10:30 AM -
11:30 AM
Friday
Fri
Event
ITI Speaker Series: Peter Katsikis, MD PhD
May 28
May 28
2026
01:00 PM -
02:00 PM
Thursday
Thu
Event
ITI Speaker Series: Alessandro Sette, Dr.Biol.Sci.
October 28
Oct 28
2026
9:00AM -
5:00PM
Wednesday
Wed
In-person & Online
Event
Stanford Human Immunity Symposium 2026
ITI in the Spotlight
March 11, 2026
– Stanford Medicine
Sepsis with Purvesh Khatri | Health Compass Podcast
March 11, 2026
– Stanford Medicine
Sepsis with Purvesh Khatri | Health Compass Podcast
Learn how we are healing patients through science & compassion
October 28, 2025
– PR Newswire
Signios Bio and Illumina Announce Winners of the Illumina-Signios Bio Proteomics Grant Program
/PRNewswire/ -- Signios Biosciences ("Signios Bio"), a science-first biotechnology company leading in multiomics and AI-powered bioinformatics, in...
September 29, 2025
– Stanford Medicine News Center
Immune cell ‘signatures’ could help guide treatment for critically ill patients
Stanford Medicine researchers have devised an immune system assessment tool that could help guide treatment for critical care patients.